Document:

<Page>

                                                                    EXHIBIT 10.1

              INDEPENDENT AUDITORS' REPORT ON SCHEDULE AND CONSENT
              ----------------------------------------------------

The Supervisory Board
DaimlerChrysler AG:

The audits of DaimlerChrysler AG and subsidiaries ("DaimlerChrysler") referred
to in our report dated February 8, 2002, included the related financial
statement schedule for each of the years in the three-year period ended December
31, 2001, as contained in the DaimlerChrysler Annual Report on Form 20-F for the
year ended December 31, 2001. The financial statement schedule is the
responsibility of DaimlerChrysler's management. Our responsibility is to express
an opinion on the financial statement schedule based on our audits. In our
opinion, based on our audits and the report of other auditors, such financial
statement schedule, when considered in relation to the basic consolidated
financial statements taken as a whole, presents fairly in all material respects
the information set forth therein.

Our report refers to DaimlerChrysler's adoption in 2000 of Statement of
Financial Accounting Standards No. 133, "Accounting for Derivative Instruments
and Hedging Activities," and Emerging Issues Task Force Issue No. 99-20,
"Recognition of Interest Income and Impairment on Purchased and Retained
Beneficial Interests in Securitized Financial Assets."

We consent to incorporation by reference in the registration statements on Form
F-3 (No. 333-13160) of DaimlerChrysler North America Holding Corporation and the
registration statements on Form S-8 (Nos. 333-5074, 333-7082 and 333-8998) of
DaimlerChrysler AG of our report dated February 8, 2002, relating to the
consolidated balance sheets of DaimlerChrysler as of December 31, 2001 and 2000,
and the related consolidated statements of income (loss), changes in
stockholders' equity and cash flows for each of the years in the three-year
period ended December 31, 2001, and related financial statement schedule. Such
consolidated financial statements were prepared in accordance with generally
accepted accounting principles in the United States of America. Our report with
respect thereto appears in the DaimlerChrysler Annual Report on Form 20-F for
the year ended December 31, 2001, and was based in part on the report of other
auditors. As discussed above, our report also refers to DaimlerChrysler's
adoption in 2000 of Statement of Financial Accounting Standards No. 133,
"Accounting for Derivative Instruments and Hedging Activities," and Emerging
Issues Task Force Issue No. 99-20, "Recognition of Interest Income and
Impairment on Purchased and Retained Beneficial Interests in Securitized
Financial Assets."

                                          KPMG Deutsche Treuhand-Gesellschaft AG

Stuttgart, Germany
February 20, 2002<Page>

                                                                    EXHIBIT 10.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference of our report dated February 8,
2001 (relating to the consolidated financial statements of DaimlerChrysler
Corporation not presented separately herein), included as Exhibit 10.3 of this
Annual Report on Form 20-F of DaimlerChrysler AG for the year ended December 31,
2001, in the following Registration Statements:

                  REGISTRATION
FORM              STATEMENT NO.             ISSUER

F-3               333-13160                 DaimlerChrysler North America
                                            Holding Corporation

S-8               333-5074                  DaimlerChrysler AG

S-8               333-7082                  DaimlerChrysler AG

S-8               333-8998                  DaimlerChrysler AG

Deloitte & Touche LLP

Detroit, Michigan
February 20, 2002<Page>

                                                                    EXHIBIT 10.3

INDEPENDENT AUDITORS' REPORT

Board of Directors
DaimlerChrysler Corporation
Auburn Hills, Michigan

We have audited the consolidated balance sheet of DaimlerChrysler Corporation
and consolidated subsidiaries (the "Company") as of December 31, 2000 and the
related consolidated statements of income and cash flows for each of the two
years in the period ended December 31, 2000. Such consolidated financial
statements are not included herein. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits. We did not audit the
financial statements of Chrysler Financial Company L.L.C. (a consolidated
subsidiary) for the years ended December 31, 2000 and 1999, which statements
reflect total assets constituting 50% of consolidated total assets as of
December 31, 2000 and total revenues constituting 13% and 5% of consolidated
total revenues for the years ended December 31, 2000 and 1999, respectively.
Those financial statements were audited by other auditors whose report has been
furnished to us, and our opinion, insofar as it relates to the amounts included
for Chrysler Financial Company L.L.C. for the years ended December 31, 2000 and
1999, is based solely on the report of such other auditors.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits and the report of
other auditors provide a reasonable basis for our opinion.

In our opinion, based on our audits and the report of other auditors, such
consolidated financial statements present fairly, in all material respects, the
financial position of DaimlerChrysler Corporation and its consolidated
subsidiaries at December 31, 2000 and the results of their operations and their
cash flows for each of the two years in the period ended December 31, 2000, in
conformity with accounting principles generally accepted in the United States of
America.

The Company adopted the provisions of the Financial Accounting Standards Board's
Statement of Financial Accounting Standards (SFAS) No. 133, ACCOUNTING FOR
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES, on January 1, 2000, and SFAS 138,
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES -- AN AMENDMENT OF
SFAS 133, and Emerging Issues Task Force Issue No. 99-20, RECOGNITION OF
INTEREST INCOME AND IMPAIRMENT ON PURCHASED AND RETAINED BENEFICIAL INTERESTS IN
SECURITIZED FINANCIAL ASSETS, on July 1, 2000.

Deloitte & Touche LLP

Detroit, Michigan
February 8, 2001QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.2    
  

 
 

AMENDMENT TO RIGHTS AGREEMENT    
  

        1.    General Background.    In accordance with Section 27 of the Rights Agreement between First Chicago Trust
Company of New York (the "Rights Agent") and Caremark Rx, Inc. (the "Company"), dated February 1, 2001 (the "Agreement"), the Rights Agent and the Company, desire to amend the Agreement. 

        2.    Effectiveness.    This Amendment shall be effective as of November 7, 2001 (the "Amendment") and all
defined terms and definitions in the Agreement shall be the same in the Amendment except as specifically revised by the Amendment. 

        3.    Revision.    Section 21 in the Agreement entitled "Change of Rights Agent" is hereby deleted in its
entirety and replaced with the following: 

        Change of Rights Agent.    The Rights Agent or any successor Rights Agent may resign and be discharged from its duties under
this Rights Agreement upon 30 days' notice in writing mailed to the Company and to each transfer agent of the Common Shares or Preferred Shares by registered or certified mail, and to the
holders of the Right Certificates by first-class mail. The Company may remove the Rights Agent or any successor Rights Agent, as the case may be, upon 30 days' notice in writing to the Rights
Agent or any successor Rights Agent, as the case may be, and to each transfer agent of the Common Shares or Preferred Shares by registered or certified mail, and to the holders of the Right
Certificates by first-class mail. If the Rights Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint a successor to the Rights Agent. If the
Company shall fail to make such appointment within a period of 30 days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the
resigning or incapacitated Rights Agent, then the registered holder of any Right Certificate may submit to the Company a written request (together with such holder's Right Certificate for inspection
by the Company) that the Company appoint a successor Rights Agent. If the Company shall not have appointed a successor Rights Agent within 30 days after receiving such request, such holder may
apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the Company or by such a court, shall be a corporation or trust
company organized and doing business
under the laws of the United States, in good standing, which is authorized under such laws to exercise corporation trust or stock transfer powers and is subject to supervision or examination by
federal or state authority and which has individually or combined with an Affiliate at the time of its appointment as Rights Agent a combined capital and surplus of at least $100 million
dollars. After appointment, the successor Rights Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent without further act
or deed; but the predecessor Rights Agent shall deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance,
conveyance, act or deed necessary for the purpose. Not later than the effective date of any such appointment the Company shall file notice thereof in writing with the predecessor Rights Agent and each
transfer agent in the Common Shares or Preferred Shares, and mail a notice thereof in writing to the registered holders of the Right Certificates. Failure to give any notice provided for in this
Section 21 however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the
case may be. 

        Except
as amended hereby, the Agreement and all schedules or exhibits thereto shall remain in full force and effect. 

        IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in their names and on their behalf by and through their
duly authorized officers, as of this 7th day of November, 2001. 

	Caremark Rx, Inc.	 	First Chicago Trust Company
	
/s/  SARA J. FINLEY    

By: Sara J. Finley

Title: SVP and Corporate Secretary	
 	

/s/  THOMAS GRAYMAN    

By: Thomas Grayman

Title: Senior Managing Director

QuickLinks

Exhibit 4.2

AMENDMENT TO RIGHTS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]